PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.\', \'Department of Public Health Sciences, University of Virginia, Charlottesville.\', \'Research and Clinical Trial Analytics Team, Division of Quality Performance Improvement, University of Virginia, Charlottesville.\', \'Inova Heart and Vascular Institute, Inova Health System, Falls Church, Virginia.\', \'Office of Clinical Research, Sentara Healthcare, Norfolk, Virginia.\', \'Division of Infectious Diseases, Virginia Commonwealth University, Richmond.\', \'Virginia Department of Health, Richmond.\', \'Carilion Clinic, Roanoke, Virginia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamanetworkopen.2020.35234
?:doi
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 33555331
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all